Summary of the influenza vaccine recommendations made in the joint Department of Health and Social Care, Public Health England and NHS England “annual flu letter”

Age 2–17 yearsQuadrivalent LAIV
Age 18–64 years (in clinical high-risk group due to illness, plus pregnant women, those in residential homes, carers, close contacts of immunocompromised)Quadrivalent influenza vaccine: standard egg-grown or newly licensed cell-based vaccines
Age ≥65 yearsAdjuvanted trivalent influenza vaccine or cell-based quadrivalent influenza vaccine. High-dose trivalent vaccine is licensed, but not currently funded under the NHS as it has a significantly higher price

LAIV: live attenuated influenza vaccine; NHS: National Health Service.